Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Liver X receptor unlinks intestinal regeneration and tumorigenesis
Indexado
WoS WOS:001359339900001
Scopus SCOPUS_ID:85209738764
DOI 10.1038/S41586-024-08247-6
Año 2024
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Liver X receptor drives epithelial Areg-mediated intestinal regeneration, while preventing tumour growth through adaptive immune responses.

Revista



Revista ISSN
Nature 0028-0836

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Multidisciplinary Sciences
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Das, Srustidhar - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
2 Parigi, S. Martina - Karolinska Inst - Suecia
Univ Hosp - Suecia
Rockefeller Univ - Estados Unidos
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
Rockefeller University - Estados Unidos
3 Luo, Xinxin - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
4 Fransson, Jennifer - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
5 Kern, Bianca C. - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
6 Okhovat, Ali - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
7 Diaz, Oscar E. - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
8 Sorini, Chiara - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
9 Czarnewski, Paulo - Karolinska Inst - Suecia
Univ Hosp - Suecia
Stockholm Univ - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
Science for Life Laboratory - Suecia
10 Webb, Anna T. - Karolinska Inst - Suecia
Karolinska Institutet - Suecia
11 Morales, Rodrigo A. - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
12 Lebon, Sacha - Weizmann Inst Sci - Israel
Weizmann Institute of Science Israel - Israel
13 Monasterio, Gustavo - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
14 Castillo, Francisca - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
15 Tripathi, Kumar P. - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
16 He, Ning - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
17 Pelczar, Penelope - Univ Klinikum Hamburg Eppendorf - Alemania
Universitätsklinikum Hamburg-Eppendorf - Alemania
18 Schaltenberg, Nicola - Univ Klinikum Hamburg Eppendorf - Alemania
Universitätsklinikum Hamburg-Eppendorf - Alemania
19 De la Fuente, Marjorie - Universidad Finis Terrae - Chile
Universidad de Chile - Chile
20 Lopez-Kostner, Francisco - Universidad de Los Andes, Chile - Chile
Universidad De Los Andes, Merida - Venezuela
21 Nylen, Susanne - Karolinska Inst - Suecia
Karolinska Institutet - Suecia
22 Larsen, Hjalte List - Univ Copenhagen - Dinamarca
Københavns Universitet - Dinamarca
23 Kuiper, Raoul - Norwegian Vet Inst - Noruega
Karolinska Inst - Suecia
Veterinærinstituttet - Noruega
Karolinska Institutet - Suecia
24 Antonson, Per - Karolinska Inst - Suecia
Karolinska Institutet - Suecia
25 Hermoso, Marcela A. - Universidad de Chile - Chile
26 Huber, Samuel - Univ Klinikum Hamburg Eppendorf - Alemania
Universitätsklinikum Hamburg-Eppendorf - Alemania
27 Biton, Moshe - Weizmann Inst Sci - Israel
Weizmann Institute of Science Israel - Israel
28 Scharaw, Sandra - Karolinska Inst - Suecia
Max Planck Inst Mol Cell Biol & Genet - Alemania
Karolinska Institutet - Suecia
Max Planck Institute of Molecular Cell Biology and Genetics - Alemania
29 Gustafsson, Jan-Ake - Karolinska Inst - Suecia
UNIV HOUSTON - Estados Unidos
29 Gustafsson, Jan Åke - Karolinska Institutet - Suecia
College of Natural Sciences and Mathematics - Estados Unidos
UNIV HOUSTON - Estados Unidos
30 Katajisto, Pekka - Karolinska Inst - Suecia
Univ Helsinki - Finlandia
Karolinska Institutet - Suecia
Institute of Biotechnology - Finlandia
31 Villablanca, Eduardo J. - Karolinska Inst - Suecia
Univ Hosp - Suecia
Karolinska Univ Hosp - Suecia
Karolinska Institutet - Suecia
Center of Molecular Medicine - Suecia
Karolinska Universitetssjukhuset - Suecia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
China Scholarship Council
European Union
European Research Council
Swedish Research Council
European Research Council (ERC)
Vetenskapsradet
Novo Nordisk Foundation
Horizon 2020 Framework Programme
Cancerfonden
European Federation of Pharmaceutical Industries and Associations
Kungliga Tekniska Högskolan
Ontario Institute for Cancer Research
Novo Nordisk Fonden
FORMAS
Swedish Research Council VR
Swedish National Infrastructure for Computing (SNIC)
Svenska Forskningsradet Formas
Ake Wiberg Stiftelse
Innovative Medicines Initiative
EFPIA
Silicon Valley Community Foundation
Chan Zuckerberg Initiative
Innovative Medicines Initiative 2 Joint Undertaking (JU)
SciLifeLab
Chan Zuckerberg Initiative DAF
Diamond Light Source Limited
Kungliga Tekniska Hoegskolan
BioImage Informatics Facility, a unit of the National Bioinformatics Infrastructure Sweden NBIS
Ake Weibergs Stiftelse
National Bioinformatics Infrastructure Sweden (NBIS)
Wallenberg Academy Fellow
National Microscopy Infrastructure NMI
Royal Institution for the Advancement of Learning McGill University
Royal Institution
BioImage Informatics Facility
Diamond Light Source
Novo Nordisk Foundation Centre for Stem Cell Medicine

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
We thank the Villablanca laboratory members for discussions; N. Nedelsky for editorial assistance; S. Inampudi and M. Shaik for their help with experiments; the staff at the FENO facility for tissue processing. The computations/data handling was enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC), under project number SNIC 2017/7-445 and partially funded by the Swedish Research Council through grant agreement no. 2018-05973. We also thank the staff at the National Bioinformatics Infrastructure Sweden (NBIS) long-term support. The analysis pipeline for salivary glands has been made possible in part by BioImage Informatics Facility, a unit of the National Bioinformatics Infrastructure Sweden NBIS, with funding from SciLifeLab, National Microscopy Infrastructure NMI (VR-RFI 2019-00217) and Chan Zuckerberg Initiative DAF (DAF2021-225261, https://doi.org/10.37921/644085ggkbos, an advised fund of Silicon Valley Community Foundation, https://doi.org/10.13039/100014989). The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW) are supported by a Novo Nordisk Foundation grant number NNF21CC0073729. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875510. The JU receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA and Ontario Institute for Cancer Research, Royal Institution for the Advancement of Learning McGill University, Kungliga Tekniska Hoegskolan, Diamond Light Source Limited. This communication reflects the views of the authors and the JU is not liable for any use that may be made of the information contained herein. X.L. was supported by grants from China Scholarship Council (nr. 201907930012). S.D. was supported by Cancerfonden (CAN 2016/1206), ake Weibergs Stiftelse (M21-0074, M22-0048, M23-0179); and E.J.V. by grants from the Swedish Research Council VR (K2015-68X-22765-01-6, 2018-02533 and 2021-01277), FORMAS (FR-2016/0005 and 2022-01066), Cancerfonden (19 0395 Pj and 22 2060 Pj), European Research Council (ERC) Synergy Grant 101118531, and Wallenberg Academy Fellow (WAF) program (2019.0315 and 2024.0135).
We thank the Villablanca laboratory members for discussions; N. Nedelsky for editorial assistance; S. Inampudi and M. Shaik for their help with experiments; the staff at the FENO facility for tissue processing. The computations/data handling was enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC), under project number SNIC 2017/7-445 and partially funded by the Swedish Research Council through grant agreement no. 2018-05973. We also thank the staff at the National Bioinformatics Infrastructure Sweden (NBIS) long-term support. The analysis pipeline for salivary glands has been made possible in part by BioImage Informatics Facility, a unit of the National Bioinformatics Infrastructure Sweden NBIS, with funding from SciLifeLab, National Microscopy Infrastructure NMI (VR-RFI 2019-00217) and Chan Zuckerberg Initiative DAF (DAF2021-225261, https://doi.org/10.37921/644085ggkbos, an advised fund of Silicon Valley Community Foundation, https://doi.org/10.13039/100014989). The Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW) are supported by a Novo Nordisk Foundation grant number NNF21CC0073729. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875510. The JU receives support from the European Union\u2019s Horizon 2020 research and innovation programme and EFPIA and Ontario Institute for Cancer Research, Royal Institution for the Advancement of Learning McGill University, Kungliga Tekniska Hoegskolan, Diamond Light Source Limited. This communication reflects the views of the authors and the JU is not liable for any use that may be made of the information contained herein. X.L. was supported by grants from China Scholarship Council (nr. 201907930012). S.D. was supported by Cancerfonden (CAN 2016/1206), \u00C5ke Weibergs Stiftelse (M21-0074, M22-0048, M23-0179); and E.J.V. by grants from the Swedish Research Council VR (K2015-68X-22765-01-6, 2018-02533 and 2021-01277), FORMAS (FR-2016/0005 and 2022-01066), Cancerfonden (19 0395 Pj and 22 2060 Pj), European Research Council (ERC) Synergy Grant 101118531, and Wallenberg Academy Fellow (WAF) program (2019.0315 and 2024.0135).

Muestra la fuente de financiamiento declarada en la publicación.